Heart Care Lifescience Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.72 M
- Company Age 14 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 5.00 M
- Revenue Growth -32.44%
- Profit Growth -40.17%
- Ebitda -41.44%
- Net Worth 4.49%
- Total Assets -12.49%
About Heart Care Lifescience
Heart Care Lifescience Private Limited (HCLPL) is a Private Limited Indian Non-Government Company incorporated in India on 01 April 2010 and has a history of 14 years and ten months. Its registered office is in Surat, Gujarat, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.72 M.
The company has closed loans amounting to ₹5.00 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Alka Rabadia, Parina Patel, and Manojkumar Rabadia serve as directors at the Company.
Company Details
- Location
Surat, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24230GJ2010PTC060109
- Company No.
060109
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Apr 2010
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Heart Care Lifescience?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manojkumar Rabadia  | Managing Director | 01-Apr-2010 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Alka Rabadia | Director | 01-Apr-2010 | Current |
| Parina Patel | Director | 01-Apr-2010 | Current |
Financial Performance of Heart Care Lifescience.
Heart Care Lifescience Private Limited, for the financial year ended 2017, experienced significant reduction in revenue, with a 32.44% decrease. The company also saw a substantial fall in profitability, with a 40.17% decrease in profit. The company's net worth moved up by a moderate rise of 4.49%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Heart Care Lifescience?
In 2017, Heart Care Lifescience had a promoter holding of 96.93% and a public holding of 3.07%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0
₹5.00 M
Charges Breakdown by Lending Institutions
- Punjab National Bank : 0.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 08 Apr 2011 | Punjab National Bank | ₹5.00 M | Satisfied |
How Many Employees Work at Heart Care Lifescience?
Unlock and access historical data on people associated with Heart Care Lifescience, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Heart Care Lifescience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Heart Care Lifescience's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED_354462.webp){kind=small}
